Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03738254 · ClinicalTrials.gov registry record · NA
Motivating Survey Compliance: Game Play Study 1
A NA study, sponsored by Massachusetts Institute of Technology.
- Completed
- Registry status
- NA
- Development phase
- 232
- Enrollment target
NCT03738254: Completed NA study, sponsored by Massachusetts Institute of Technology.
NCT03738254 is a NA study that has completed, run by Massachusetts Institute of Technology. The registered enrollment target is 232 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03738254, a NA study, has completed, sponsored by Massachusetts Institute of Technology.
- COMPLETED
- Registry status
- NA
- Development phase
- 232 participants
- Enrollment target
Study Summary
Self-reports, especially for patients with chronic physical or mental diseases, are critical for disease research and drug development. Historically, it has been very difficult to collect self-reported data for long periods of time as it is an unpleasant and inconvenient task. Paper and digital surveys are the traditional way of collecting self-reports and have been around for a long time, but still suffer from lack of adherence despite the best efforts of researchers to remind and motivate individuals to fill them out. Mobile games, on the other hand, benefit from an enormous amount of human adherence. These video games can be played on a smartphone and have captured the attention of a wide variety of demographics. The investigators have used established game design principles to develop a mobile game to motivate individuals to fill out a daily survey. The purpose of this study is to determine which method of survey administration (paper, digital survey, or game- motivated survey) leads to the highest adherence rates for daily surveys.
Primary Outcome
For each study arm, the average adherence rate (computed as the percent of days (out of 35 total) a participant completed 100% of the daily survey questions, averaged over all participants in the study arm) will be computed and compared
Interventions
- OTHER Paper Survey
- OTHER The Guardians: A smartphone game
- OTHER Electronic Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 232 participants |
| Start Date | 2017-10-09 |
| Est. Completion | 2018-01-11 |
| Phase | NA |
What the finished NCT03738254 record still lists
NCT03738254 is an interventional study that assigns participants to a tested intervention. The registered 232 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 3 interventions - of which Paper Survey is the first listed.
NCT03738254 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03738254 about?
NCT03738254 is a clinical study titled "Motivating Survey Compliance: Game Play Study 1". Self-reports, especially for patients with chronic physical or mental diseases, are critical for disease research and drug development. Historically, it has been very difficult to collect self-reported data for long periods of time as it is an unpleasant and inconvenient task. Paper and digital surv...
What is the current status of trial NCT03738254?
This trial is currently completed. It is a NA study. The enrollment target is 232 participants. The study started on 2017-10-09. Estimated completion is 2018-01-11.
What interventions are being tested in trial NCT03738254?
The interventions under investigation include: Paper Survey (OTHER), The Guardians: A smartphone game (OTHER), Electronic Survey (OTHER).
Who is sponsoring clinical trial NCT03738254?
This trial is sponsored by Massachusetts Institute of Technology, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03738254's enrollment target sits among peer trials
232 463rd of 2000 higher than 1,536 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01356290 · 232 participants · Phase 2
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- NCT04753359 · 232 participants · NA
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer
- NCT04770870 · 232 participants · NA
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System
- NCT05948943 · 232 participants · Phase 2
Alpelisib in Pediatric and Adult Patients With Lymphatic Malformations Associated With a PIK3CA Mutation.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI